Used in pharmaceutical research as an intermediate in the synthesis of protease inhibitors, particularly in the development of antiviral agents. Its structure supports the design of transition-state analogs that mimic peptide substrates, enhancing binding affinity to enzyme active sites. Commonly employed in medicinal chemistry for optimizing drug candidates targeting hepatitis C and other viral diseases. Also utilized in structure-activity relationship (SAR) studies to improve metabolic stability and selectivity.